Lung cancer proved the second-most discussed cancer type during ASCO 2025, totalling 2,995 mentions by more than 530 HCPs. As ...

Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...

Cambridge, Massachusetts-based Nuvalent has reported the results of its phase 1/2 ARROS-1 trial of zidesamtinib in previously ...

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

Returning to Boston for its 13 th edition, the IMPACCT Real-World Evidence Summit remains the go-to meeting for RWE experts ...

Medistry’s role is that of the registry operator of the .med zone on the World Wide Web. Medistry permits authorised domain ...

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...

Louisiana Senator Bill Cassidy, who chairs the Senate Health, Education, Labor, & Pensions (HELP) Committee, has called for ...